ribavirin has been researched along with Complications of Diabetes Mellitus in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (25.00) | 29.6817 |
| 2010's | 8 (66.67) | 24.3611 |
| 2020's | 1 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, KC; Chen, CH; Hu, TH; Hung, CH; Kuo, FY; Lin, JT; Lin, MT; Lu, SN; Tsai, MC; Tseng, PL; Wang, JH; Wu, CK; Yen, YH | 1 |
| Dohmen, K; Ichiki, Y; Ishibashi, H; Kawano, A; Miki, K; Morita, C; Nomura, H; Shigematsu, H; Shimoda, S; Takahashi, K; Yanagita, K | 1 |
| Wahid, B | 1 |
| Addis, MF; Babudieri, S; Cossu-Rocca, P; Dore, MP; Madeddu, G; Massarelli, G; Mura, MS; Nieddu, P; Pagnozzi, D; Soddu, A; Tanca, A; Uzzau, S | 1 |
| Hisanaga, Y; Ito, T; Kanamori, A; Kiriyama, S; Kitabatake, S; Kumada, T; Tada, T; Tanikawa, M; Toyoda, H | 1 |
| Akuta, N; Arase, Y; Hirakawa, M; Hosaka, T; Ikeda, K; Kawamura, Y; Kobayashi, M; Kumada, H; Saitoh, S; Sezaki, H; Suzuki, F; Suzuki, Y; Yatsuji, H | 1 |
| Albrecht, JK; Bloomer, JR; Boparai, N; Brass, CA; Brown, KA; Galler, GW; Ghalib, RH; Herrine, SK; Jiang, R; King, JW; McCone, J; McHutchison, JG; Melia, MT; Muir, AJ; Mullen, KD; Noviello, S; Nunes, FA; Ravendhran, N; Shiffman, ML; Sulkowski, MS | 1 |
| Kang, P; Sun, LJ; Yan, BZ; Yu, JW; Zhao, YH | 1 |
| Tai, YK; Tsai, CY; Wu, CS | 1 |
| Bai, Y; Cai, BQ; Cao, B; Li, LY; Li, TS; Liu, ZY; Lu, WX; Wang, MZ; Wang, Z; Xu, WB; Xu, ZJ; Zhu, YJ | 1 |
| Bräu, N; Eldeiry, LS; Greenberg, PD; Naqvi, Z; Rosman, AS | 1 |
| Akuta, N; Arase, Y; Hosaka, T; Ikeda, K; Kawamura, Y; Kobayashi, M; Kumada, H; Sezaki, H; Suzuki, F; Suzuki, Y; Yatsuji, H | 1 |
1 trial(s) available for ribavirin and Complications of Diabetes Mellitus
| Article | Year |
|---|---|
Side effects of combination therapy of peginterferon and ribavirin for chronic hepatitis-C.
Topics: Adolescent; Adult; Age Factors; Aged; Diabetes Complications; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Hypertension; Interferon alpha-2; Interferon-alpha; Liver Cirrhosis; Male; Middle Aged; Polyethylene Glycols; Prospective Studies; Recombinant Proteins; Ribavirin; Treatment Refusal; Viral Load | 2007 |
11 other study(ies) available for ribavirin and Complications of Diabetes Mellitus
| Article | Year |
|---|---|
The association between steatosis and diabetes with hepatocellular carcinoma in non-genotype 3 chronic hepatitis C patients.
Topics: Adult; Antiviral Agents; Carcinoma, Hepatocellular; Diabetes Complications; Diabetes Mellitus; Fatty Liver; Female; Genotype; Hepatitis C, Chronic; Humans; Interferons; Kaplan-Meier Estimate; Liver Neoplasms; Male; Middle Aged; Multivariate Analysis; Proportional Hazards Models; Retrospective Studies; Ribavirin; Risk Factors; Sustained Virologic Response; Taiwan | 2018 |
Diabetes Mellitus Prevents an Improvement in the Serum Albumin Level During Interferon-free Sofosbuvir-based Therapy for Chronic Hepatitis C Patients: A Multi-institutional Joint Study.
Topics: Adult; Aged; Antiviral Agents; Benzimidazoles; Diabetes Complications; Drug Therapy, Combination; Female; Fluorenes; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Interferons; Liver Cirrhosis; Logistic Models; Male; Middle Aged; Retrospective Studies; Ribavirin; Serum Albumin; Sofosbuvir; Uridine Monophosphate | 2018 |
Successful treatment of HBV, HCV, & HEV, with 12-week long use of tenofovir, sofosbuvir, daclatasvir, and ribavirin: A case report.
Topics: Aged; Antiviral Agents; Asthma; Carbamates; Coinfection; Diabetes Complications; Drug Administration Schedule; Drug Therapy, Combination; Hepatitis B; Hepatitis C, Chronic; Hepatitis E; Humans; Imidazoles; Male; Pyrrolidines; Ribavirin; Sofosbuvir; Tenofovir; Treatment Outcome; Valine; Viral Load | 2020 |
Proteomic characterization of hepatitis C eradication: enzyme switch in the healing liver.
Topics: Adult; Alcoholism; Antiviral Agents; Diabetes Complications; Female; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Liver; Polyethylene Glycols; Proteome; Proteomics; Recombinant Proteins; Ribavirin | 2013 |
Risk factors of hepatocellular carcinoma development in non-cirrhotic patients with sustained virologic response for chronic hepatitis C virus infection.
Topics: Adult; Antiviral Agents; Carcinoma, Hepatocellular; Diabetes Complications; Female; Follow-Up Studies; Forecasting; Hepatitis C, Chronic; Humans; Incidence; Interferon-alpha; Liver Neoplasms; Male; Middle Aged; Multivariate Analysis; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Risk Factors; Time Factors | 2015 |
Diabetes enhances hepatocarcinogenesis in noncirrhotic, interferon-treated hepatitis C patients.
Topics: Adolescent; Adult; Aged; Carcinoma, Hepatocellular; Diabetes Complications; Female; Hepatitis C; Humans; Interferon-alpha; Interferon-beta; Interferons; Kaplan-Meier Estimate; Liver; Liver Neoplasms; Male; Middle Aged; Multivariate Analysis; Proportional Hazards Models; Retrospective Studies; Ribavirin; Risk Factors; Time Factors; Young Adult | 2010 |
Racial differences in hepatitis C treatment eligibility.
Topics: Adult; Alcoholism; Antiviral Agents; Black People; Diabetes Complications; Eligibility Determination; Female; Heart Diseases; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Male; Mass Screening; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Renal Insufficiency; Retrospective Studies; Ribavirin; Substance-Related Disorders; Treatment Outcome; United States; White People | 2011 |
The study of relationship between neutropenia and infection during treatment with peginterferon α and ribavirin for chronic hepatitis C.
Topics: Adult; Age Factors; Antiviral Agents; Diabetes Complications; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Immunocompromised Host; Interferon-alpha; Leukocyte Count; Liver Cirrhosis; Male; Middle Aged; Neutropenia; Opportunistic Infections; Polyethylene Glycols; Recombinant Proteins; Retrospective Studies; Ribavirin; Risk Factors | 2011 |
Combination effect of ribavirin and erythropoietin treatment on hemoglobin A1c in a diabetic patient with chronic hepatitis C.
Topics: Diabetes Complications; Diabetes Mellitus, Type 2; Drug Synergism; Drug Therapy, Combination; Erythropoietin; Female; Glycated Hemoglobin; Hepatitis C, Chronic; Humans; Middle Aged; Ribavirin | 2012 |
[Clinical diagnosis, treatment and prognosis of elderly SARS patients].
Topics: Age Factors; Aged; Antiviral Agents; Diabetes Complications; Female; Humans; Hypertension; Male; Middle Aged; Prognosis; Retrospective Studies; Ribavirin; Risk Factors; Severe Acute Respiratory Syndrome | 2003 |
Decline in haemoglobin A1c values in diabetic patients receiving interferon-alpha and ribavirin for chronic hepatitis C.
Topics: Antiviral Agents; Blood Glucose; Body Weight; Diabetes Complications; Diabetes Mellitus; Erythrocyte Indices; Female; Glycated Hemoglobin; Hemoglobins; Hepatitis C, Chronic; Humans; Interferon-alpha; L-Lactate Dehydrogenase; Male; Middle Aged; Reticulocyte Count; Retrospective Studies; Ribavirin | 2006 |